| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,315 |
3,081 |
$78K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
658 |
621 |
$22K |
| 62323 |
|
314 |
289 |
$20K |
| 80305 |
|
1,313 |
1,244 |
$8K |
| 99152 |
|
466 |
427 |
$6K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
999 |
539 |
$2K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
423 |
395 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
232 |
212 |
$956.08 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
466 |
427 |
$132.19 |
| M1207 |
Patient is screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety |
110 |
107 |
$0.00 |
| M1171 |
Patient received at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period |
31 |
29 |
$0.00 |
| M1176 |
Patient did not receive two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period |
27 |
26 |
$0.00 |
| M1170 |
Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period |
29 |
29 |
$0.00 |